The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Neurofibroma


High impact information on Neurofibroma


Chemical compound and disease context of Neurofibroma


Biological context of Neurofibroma


Anatomical context of Neurofibroma


Gene context of Neurofibroma


Analytical, diagnostic and therapeutic context of Neurofibroma


  1. A de novo Alu insertion results in neurofibromatosis type 1. Wallace, M.R., Andersen, L.B., Saulino, A.M., Gregory, P.E., Glover, T.W., Collins, F.S. Nature (1991) [Pubmed]
  2. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Eisenbarth, I., Beyer, K., Krone, W., Assum, G. Am. J. Hum. Genet. (2000) [Pubmed]
  3. A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors. Cappione, A.J., French, B.L., Skuse, G.R. Am. J. Hum. Genet. (1997) [Pubmed]
  4. Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2. Kaufmann, D., Leistner, W., Kruse, P., Kenner, O., Hoffmeyer, S., Hein, C., Vogel, W., Messiaen, L., Bartelt, B. Cancer Res. (2002) [Pubmed]
  5. Neurofibromatosis type 1: pathology, clinical features and molecular genetics. von Deimling, A., Krone, W., Menon, A.G. Brain Pathol. (1995) [Pubmed]
  6. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. Serra, E., Rosenbaum, T., Nadal, M., Winner, U., Ars, E., Estivill, X., Lázaro, C. Nat. Genet. (2001) [Pubmed]
  7. Mouse models of tumor development in neurofibromatosis type 1. Cichowski, K., Shih, T.S., Schmitt, E., Santiago, S., Reilly, K., McLaughlin, M.E., Bronson, R.T., Jacks, T. Science (1999) [Pubmed]
  8. Angiogenic and invasive properties of neurofibroma Schwann cells. Sheela, S., Riccardi, V.M., Ratner, N. J. Cell Biol. (1990) [Pubmed]
  9. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Serra, E., Puig, S., Otero, D., Gaona, A., Kruyer, H., Ars, E., Estivill, X., Lázaro, C. Am. J. Hum. Genet. (1997) [Pubmed]
  10. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Serra, E., Rosenbaum, T., Winner, U., Aledo, R., Ars, E., Estivill, X., Lenard, H.G., Lázaro, C. Hum. Mol. Genet. (2000) [Pubmed]
  11. Progesterone receptor expression in neurofibromas. McLaughlin, M.E., Jacks, T. Cancer Res. (2003) [Pubmed]
  12. Tissue culture studies of neurofibromatosis: effects of axolemmal fragments and cyclic adenosine 3',5'-monophosphate analogues on proliferation of Schwann-like and fibroblast-like neurofibroma cells. Sobue, G., Sonnenfeld, K., Rubenstein, A.E., Pleasure, D. Ann. Neurol. (1985) [Pubmed]
  13. Early lesion of N-nitroso-N-ethylurea-induced hamster neurofibromatosis model. Nakamura, T., Hara, M., Kasuga, T. Cancer Res. (1991) [Pubmed]
  14. Neurofibromas: location by scanning with Tc-99m DTPA. Work in progress. Mandell, G.A., Herrick, W.C., Harcke, H.T., Sharkey, C., Brooks, K.M., MacEwen, G.D. Radiology. (1985) [Pubmed]
  15. Solitary cutaneous plexiform neurilemmoma (schwannoma): a clinicopathologic, immunohistochemical, and ultrastructural study of 11 cases. Kao, G.F., Laskin, W.B., Olsen, T.G. Mod. Pathol. (1989) [Pubmed]
  16. neu proto-oncogene mutation is specific for the neurofibromas in a N-nitroso-N-ethylurea-induced hamster neurofibromatosis model but not for hamster melanomas and human Schwann cell tumors. Nakamura, T., Ushijima, T., Ishizaka, Y., Nagao, M., Nemoto, T., Hara, M., Ishikawa, T. Cancer Res. (1994) [Pubmed]
  17. Alterations of microsatellites in neurofibromas of von Recklinghausen's disease. Ottini, L., Esposito, D.L., Richetta, A., Carlesimo, M., Palmirotta, R., Verí, M.C., Battista, P., Frati, L., Caramia, F.G., Calvieri, S. Cancer Res. (1995) [Pubmed]
  18. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene. Sherman, L., Jacoby, L.B., Lampe, J., Pelton, P., Aguzzi, A., Herrlich, P., Ponta, H. Cancer Res. (1997) [Pubmed]
  19. Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells. Sonnenfeld, K.H., Bernd, P., Sobue, G., Lebwohl, M., Rubenstein, A.E. Cancer Res. (1986) [Pubmed]
  20. Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cell. Nakamura, T., Nemoto, T., Arai, M., Yamazaki, Y., Kasuga, T., Gutmann, D.H., Collins, F.S., Ishikawa, T. Am. J. Pathol. (1994) [Pubmed]
  21. S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Stefansson, K., Wollmann, R., Jerkovic, M. Am. J. Pathol. (1982) [Pubmed]
  22. Non-specificity of anti-carbonic anhydrase C antibody as a marker in human neurooncology. Nakagawa, Y., Perentes, E., Rubinstein, L.J. J. Neuropathol. Exp. Neurol. (1987) [Pubmed]
  23. Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas. Krasnoselsky, A., Massay, M.J., DeFrances, M.C., Michalopoulos, G., Zarnegar, R., Ratner, N. J. Neurosci. (1994) [Pubmed]
  24. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. Mashour, G.A., Ratner, N., Khan, G.A., Wang, H.L., Martuza, R.L., Kurtz, A. Oncogene (2001) [Pubmed]
  25. Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Papadopoulos, E.J., Fitzhugh, D.J., Tkaczyk, C., Gilfillan, A.M., Sassetti, C., Metcalfe, D.D., Hwang, S.T. Eur. J. Immunol. (2000) [Pubmed]
  26. Glial fibrillary acidic protein and keratin expression by benign and malignant nerve sheath tumors. Gray, M.H., Rosenberg, A.E., Dickersin, G.R., Bhan, A.K. Hum. Pathol. (1989) [Pubmed]
  27. Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Muir, D., Neubauer, D., Lim, I.T., Yachnis, A.T., Wallace, M.R. Am. J. Pathol. (2001) [Pubmed]
  28. Basement membrane proteins, interstitial collagens, and fibronectin in neurofibroma. Fleischmajer, R., Timpl, R., Dziadek, M., Lebwohl, M. J. Invest. Dermatol. (1985) [Pubmed]
  29. SPECT imaging of para-axial neurofibromatosis with technetium-99m DTPA. Mandell, G.A., Harcke, H.T., Sharkey, C., Brooks, K.M., MacEwen, G.D. J. Nucl. Med. (1987) [Pubmed]
  30. Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1. Cunha, K.S., Barboza, E.P., Da Fonseca, E.C. J. Clin. Pathol. (2003) [Pubmed]
  31. Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression. Muir, D. Clin. Exp. Metastasis (1995) [Pubmed]
WikiGenes - Universities